Evidence to inform biopharmaceutical policy: call for research on the impact of public policies on investment in drug development.

ABSTRACT: This paper highlights the pressing need for updated, robust evidence to inform biopharmaceutical policy, particularly in light of recent initiatives such as the Inflation Reduction Act. Current estimates that inform such policies, including those from the Congressional Budget Office, rely on outdated data and models that fail to fully capture the complexities of modern investment decisions or the broader impact of policies on drug development in areas like oncology, rare diseases, and vaccines. Understanding how expectations of financial returns influence investment in all stages of drug development is critical for evaluating these policies' long-term effects on innovation. This piece reviews the current evidence on the relationship between financial returns and research and development in

SUBMITTER: Barbosu S 

PROVIDER: S-EPMC11631377 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature